Ybrain
PrivateLast Round
Growth Equity
Feb 23, 2022
Total Funding Raised
$24.24M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ybrain operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Growth Equity round in February 2022.
Ybrain is a healthtech company that manufactures a wearable medical device intended to measure and treat neuropsychiatric illnesses based on neuroscience.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ybrain Comparables
Compare Ybrain with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuroelectrics | 83% | |
| Flow Neuroscience | 82% | |
| Sooma | 82% |
For institutional investors. Book with your work email.
Ybrain Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 23, 2022 | ||||
| Series C | Feb 17, 2020 | ||||
| Series B | Nov 29, 2017 | ||||
| Series A | Aug 28, 2014 | ||||
| Seed | Feb 1, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ybrain Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Growth Equity |
| Company K Partners, Limited | Series A |
| KDB Capital Corp | Series B |
| DSC Investment | Series A |
| KT&G | Growth Equity |
| G.N.Tech Venture Capital | Series C |
| DTN Ventures | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 42% MoM.
- Jun 19, 2026
Monthly visitors increased 81% MoM, reaching 21K.
For institutional investors. Book with your work email.
Ybrain Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ybrain's valuation, stock price, and market status.
Is Ybrain a public or private company?
Ybrain is a private company.
What is the current stock price of Ybrain?
Ybrain is a private company, so its shares have no public market price. Caplight tracks Ybrain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ybrain worth (valuation)?
Valuation information for Ybrain is not publicly available.
Can I buy Ybrain stock?
Ybrain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ybrain's last funding round?
Ybrain's most recent funding round was Growth Equity on February 23, 2022.
Who are the main investors in Ybrain?
Key investors in Ybrain include Stonebridge Capital.
Will Ybrain IPO soon?
No public IPO plans have been announced for Ybrain.
How can I track Ybrain secondary market activity?
Caplight tracks bids, offers, and trades in Ybrain's shares on secondary markets.